1. Home
  2. SABS vs VABK Comparison

SABS vs VABK Comparison

Compare SABS & VABK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

N/A

Current Price

$4.50

Market Cap

201.4M

Sector

Health Care

ML Signal

N/A

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

N/A

Current Price

$38.51

Market Cap

206.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SABS
VABK
Founded
2014
1998
Country
United States
United States
Employees
N/A
146
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
201.4M
206.8M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
SABS
VABK
Price
$4.50
$38.51
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$9.40
N/A
AVG Volume (30 Days)
321.3K
10.8K
Earning Date
01-01-0001
04-30-2026
Dividend Yield
N/A
3.75%
EPS Growth
N/A
N/A
EPS
N/A
2.45
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$15.72
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$34.56
52 Week High
$6.60
$44.50

Technical Indicators

Market Signals
Indicator
SABS
VABK
Relative Strength Index (RSI) 65.18 42.22
Support Level $3.43 $37.40
Resistance Level $4.68 $41.19
Average True Range (ATR) 0.25 1.16
MACD 0.05 -0.15
Stochastic Oscillator 80.69 29.71

Price Performance

Historical Comparison
SABS
VABK

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

Share on Social Networks: